Stephanie N Langel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

PLoS pathogens

Microbiology spectrum

Cell death discovery

Science translational medicine

Duke Human Vaccine Institute

The Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke Human Vaccine Institute

United States

Postdoctoral Fellow

Education History

The Ohio State University

United States

PHD :: Preventive Veterinary Medicine

Publications

Philip J Kuehl, Justin Dearing, Adam Werts, Jason Cox, Hammad Irshad, Edward G Barrett, Sean N Tucker, Stephanie N Langel
Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters. Microbiology spectrum (2023)
Stephanie N Langel, David R Martinez
Antibody-mediated immunity against lung cancer goes retro. Science immunology 8 (84) (2023)
Stephanie N Langel, Susan Johnson, Clarissa I Martinez, Sarah N Tedjakusuma, Nadine Peinovich, Emery G Dora, Philip J Kuehl, Hammad Irshad, Edward G Barrett, Adam D Werts, Sean N Tucker
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model. Science translational medicine 14 (658) (2022)
Stephanie N Langel, Francine L Kelly, David M Brass, Andrew E Nagler, Dylan Carmack, Joshua J Tu, Tatianna Travieso, Ria Goswami, Sallie R Permar, Maria Blasi, Scott M Palmer
E-cigarette and food flavoring diacetyl alters airway cell morphology, inflammatory and antiviral response, and susceptibility to SARS-CoV-2. Cell death discovery 8 (1) (2022)
Stephanie N Langel, Claire E Otero, David R Martinez, Sallie R Permar
Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection. PLoS pathogens 16 (3) (2020)
Claire E Otero, Stephanie N Langel, Maria Blasi, Sallie R Permar
Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS pathogens 16 (11) (2020)

Stephanie N Langel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stephanie N Langel